Literature DB >> 16609626

[Heredity and genetic aspects of Raynaud's disease].

M A Pistorius1, B Planchon, J J Schott, H Lemarec.   

Abstract

The pathophysiology of primary Raynaud's phenomenon (Raynaud's disease) remains uncertain but the transmission of this primary microcirculatory dysregulation seems strongly influenced by genetic factors. For a long time, physicians have found that the hereditary factor plays an important role in the genesis of Raynaud's disease. Familial analysis and twin studies have confirmed the role of an hereditary factor. It seems heterogeneous but pedigree analysis indicates the possibility of an autosomal dominant transmission influenced by sex, in some families, allowing an approach called "reverse genetic" based on linkage analysis. Such an approach has focused on few loci but sequencing of candidate genes for genetic mutations remains negative. Given the supposed heterogeneity of the genetic transmission of Raynaud's disease, diversification of strategies in molecular genetics is suitable with reference to techniques applied to multifactorial heredity.

Entities:  

Mesh:

Year:  2006        PMID: 16609626     DOI: 10.1016/s0398-0499(06)76512-x

Source DB:  PubMed          Journal:  J Mal Vasc        ISSN: 0398-0499


  4 in total

Review 1.  The diagnosis and treatment of Raynaud's phenomenon: a practical approach.

Authors:  Janet E Pope
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  Raynaud's phenomenon.

Authors:  Ashraful Haque; Michael Hughes
Journal:  Clin Med (Lond)       Date:  2020-11       Impact factor: 2.659

3.  Primary Raynaud's phenomenon in an infant: a case report and review of literature.

Authors:  Anjali A Sharathkumar; Paul Castillo-Caro
Journal:  Pediatr Rheumatol Online J       Date:  2011-07-18       Impact factor: 3.054

Review 4.  Raynaud's Phenomenon: A Brief Review of the Underlying Mechanisms.

Authors:  Manal M Fardoun; Joseph Nassif; Khodr Issa; Elias Baydoun; Ali H Eid
Journal:  Front Pharmacol       Date:  2016-11-16       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.